These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20358778)

  • 1. [Normal connective tissue in penis and its changes in patients with erectile dysfunction and Peyronie's disease].
    Neĭmark AI; Klimachev VV; Gerval'd VIa; Bobrov IP; Avdalian AM; Muzalevskaia NI; Gerval'd IV; Aliev RT; Kazymov MA
    Morfologiia; 2009; 136(6):75-8. PubMed ID: 20358778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie's disease.
    Costa WS; Rebello SB; Cardoso LE; Cavalcanti AG; Sampaio FJ
    BJU Int; 2009 Jan; 103(2):212-6. PubMed ID: 18782314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction.
    Arafa M; Eid H; El-Badry A; Ezz-Eldine K; Shamloul R
    Int J Impot Res; 2007; 19(2):213-7. PubMed ID: 16915304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence.
    Akkus E; Carrier S; Baba K; Hsu GL; Padma-Nathan H; Nunes L; Lue TF
    Br J Urol; 1997 Jan; 79(1):47-53. PubMed ID: 9043496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the penis corpora cavernosa in controls and patients with erectile dysfunction.
    Costa WS; Carrerete FB; Horta WG; Sampaio FJ
    BJU Int; 2006 Mar; 97(3):567-9. PubMed ID: 16469027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction.
    Iacono F; Barra S; De Rosa G; Boscaino A; Lotti T
    J Urol; 1993 Dec; 150(6):1806-9. PubMed ID: 8230510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the pathogenesis of penile venous leakage: role of the tunica albuginea.
    Shafik A; Shafik I; El Sibai O; Shafik AA
    BMC Urol; 2007 Sep; 7():14. PubMed ID: 17803807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction.
    Gentile V; Modesti A; La Pera G; Vasaturo F; Modica A; Prigiotti G; Di Silverio F; Scarpa S
    J Androl; 1996; 17(2):96-103. PubMed ID: 8723432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate.
    Levine LA; Latchamsetty KC
    Int J Impot Res; 2002 Dec; 14(6):478-82. PubMed ID: 12494281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
    Bivalacqua TJ; Diner EK; Novak TE; Vohra Y; Sikka SC; Champion HC; Kadowitz PJ; Hellstrom WJ
    J Urol; 2000 Jun; 163(6):1992-8. PubMed ID: 10799245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease.
    Brock G; Hsu GL; Nunes L; von Heyden B; Lue TF
    J Urol; 1997 Jan; 157(1):276-81. PubMed ID: 8976279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study.
    Usta MF; Bivalacqua TJ; Tokatli Z; Rivera F; Gulkesen KH; Sikka SC; Hellstrom WJ
    J Urol; 2004 Jul; 172(1):259-62. PubMed ID: 15201789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological characteristics of Peyronie's disease].
    Kapuller LL; Derevianko VP; Novak GIa; Bukhman AA
    Arkh Patol; 1982; 44(10):49-54. PubMed ID: 7181709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
    Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
    J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyronie's disease in diabetic patients being screened for erectile dysfunction.
    El-Sakka AI; Tayeb KA
    J Urol; 2005 Sep; 174(3):1026-30. PubMed ID: 16094040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History, epidemiology, and clinical presentation of Peyronie's disease.
    Hellstrom WJ
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S91-2. PubMed ID: 14551584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.